Startseite>>Infectious Disease>> Parasitic Diseases>> Leishmaniasis>>1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate)

1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate) (Synonyms: P4S, PTS)

Katalog-Nr.GC46386

A synthetic intermediate

Products are for research use only. Not for human use. We do not sell to patients.

1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate) Chemische Struktur

Cas No.: 1771776-02-3

Größe Preis Lagerbestand Menge
500 mg
94,00 $
Auf Lager
1 g
150,00 $
Auf Lager
5 g
659,00 $
Auf Lager
10 g
942,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1,3,6,8-Pyrenetetrasulfonic acid is an intermediate in the synthesis of the color additive pyranine.1 It has been used to stabilize intermolecular interactions for the crystallization of L. mexicana pyruvate kinase.2

1.Jitian, S., White, S.R., Yang, H.-H.W., et al.Conventional high-performance liquid chromatography versus derivative spectrophotometry for the determination of 1,3,6-pyrenetrisulfonic acid trisodium salt and 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt in the color additive D&C Green No. 8 (Pyranine)J. Chromatogr. A1324238-241(2014) 2.Morgan, H.P., McNae, I.W., Hsin, K.-Y., et al.An improved strategy for the crystallization of Leishmania mexicana pyruvate kinaseActa Crystallogr. Sect. F Struct. Biol. Cryst. Commun.66(Pt 3)215-218(2010)

Bewertungen

Review for 1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.